hepatocellular carcinoma
Conditions
Interventions
Observation group:None
Sponsors
Peking University Shenzhen Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Pathological results confirmed primary liver cancer, patients aged 18-80 years; 2. Underwent surgical treatment (radical surgery or palliative surgery), with pathological confirmation of liver cancer; 3. Have undergone at least one test of tumor markers, complete blood count, blood biochemistry, and coagulation function; 4. Complete clinical case data; 5. Voluntarily signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients under 18 years old or over 80 years old; 2. Cases not confirmed by pathology; 3. Accompanied by conditions or diseases that can cause elevated AFP (such as pregnancy, yolk sac tumor, teratoma, liver dysfunction, various types of liver diseases such as acute or chronic hepatitis, liver cirrhosis, fatty liver, alcoholic liver disease, etc.); 4. No serum AFP test performed at the first visit; 5. Clinical case information is incomplete.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ZPF69B expression level; | — |
Countries
China
Contacts
Public ContactErbao Chen
Peking University Shenzhen Hospital
Outcome results
None listed